The rapidly evolving UK copyright scene is seeing a notable shift. While established psychedelics like LSD and psilocybin remain popular , a new wave of interest is focused on emerging compounds. N,N-Dimethyltryptamine, often linked to profound mystical experiences, is gaining increased attention